|
Abnova Corporation CEO Dr. Wilber Huang is invited to speak at En Chu Kong Hospital in New Taipei City, Taiwan. Dr. Huang’s speech highlights the prostate cancer germline service.
Invited Speaker: Wilber Huang, MD Topic: Prostate Cancer Germline Service Date: November 8th, 2019 Venue: Department of Urology at En Chu Kong Hospital |
+886-2-87511888
sales@abnova.com
Abnova has established a comprehensive portfolio of fully integrated solutions to address the needs of the in vitro diagnostic (IVD) industry. Abnova provides its partners and customers access to the technologies, products, and services relating to circulating rare cells, circulating exosomes, and circulating cell-free RNA for early to metastatic to recurrent disease and treatment diagnosis, prediction, guidance, and monitoring. Abnova facility is for proprietary bioreagent and high-throughput automation development and manufacturing for clinical trials and IVD commercialization. (www.abnova.com)